October 27, 2016
October 27, 2016 —
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered that a cell surface molecule known as CD98 promotes AML. The study also…
February 17, 2017
February 17, 2017 —
…PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
August 26, 2018
August 26, 2018 —
To better understand how much marijuana or constituent compounds actually get into breast milk and how long it remains, researchers at University of California San Diego School of Medicine conducted a study, publishing online in Pediatrics.
September 10, 2012
September 10, 2012 —
Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients’ outcomes.
April 29, 2024
April 29, 2024 —
A modified pacifier and AI algorithms to analyze the data it produces could determine if newborns are learning the proper mechanics of nursing, a recent study shows. Specifically, the researchers from the University of California San Diego measured if babies are generating enough suckling strength to breastfeed and whether they…
May 3, 2023
May 3, 2023 —
New treatment offered at the Regional Burn Center at UC San Diego Health uses an applied synthetic skin substitute to encourage skin growth on burn wound, giving some patients the opportunity to be discharged same-day.
September 20, 2019
September 20, 2019 —
Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer.
March 15, 2013
March 15, 2013 —
University of California, San Diego Health System has been named among “100 Hospitals with Great Neurosurgery and Spine Programs” by Becker’s Hospital Review, a news publication for hospital and health system leadership.
February 23, 2022
February 23, 2022 —
The National Institutes of Health have awarded UC San Diego a grant totaling $12.4 million. This will support a new research center dedicated to studying the human brain and central nervous system 〈CNS〉, specifically the ways they’re affected by HIV and opioids.
July 27, 2022
July 27, 2022 —
In mouse studies, UC San Diego researchers report that lactating mothers expose their feeding pups to triclosan, an antimicrobial commonly used in consumer products, resulting in early signs of liver damage.